GlassScriptPrepare for your visit
Laura M Haar
Medical · Slidell, LA · NPI 1801143599
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$7,723.45
in general payments reported to CMS, 2019-2025 · $286 in 2025
The $286 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $1,904.73
- Amgen INC. $1,305.35
- Ucb, INC. $802.35
- Novartis Pharmaceuticals Corporation $503.76
- Janssen Biotech, INC. $415.91
- Pfizer INC. $400.76
Drugs and devices associated with these payments
Rinvoq Enbrel Otezla Cimzia Benlysta Evenity Cosentyx Acthar Tremfya Tavneos Xeljanz Skyrizi
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Laura Haar listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10686167/laura-m-haar